Evaluating Safety of COR-1389

We are studying a new medication called COR-1389 to see how safe it is and how well the body tolerates it. This research may help improve treatment options in the future.

1-2 yearsSafety phase (I)EndocrinologyNephrology

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
PROFIL Institut fuer Stoffwechselforschung GmbH
Neuss, Germany
Sponsor: Corteria Pharmaceuticals
Last updated: Nov 27, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.